Advances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.

Optics and Spectroscopy is a pivotal peer-reviewed journal published by Pleiades Publishing Inc, focusing on the intricate fields of atomic and molecular physics, as well as optics. Established in 1972, and enjoying a legacy of convergence periods that reinforce its commitment to the evolving landscape of these scientific domains, the journal aims to disseminate high-quality research that advances our understanding of light-matter interactions, electronic materials, and spectroscopic techniques. Despite its current Q4 categorization in both the Atomic and Molecular Physics and Electronic, Optical and Magnetic Materials fields, with corresponding Scopus rankings reflecting its developing influence, the journal remains a valuable resource for researchers and professionals seeking to publish their findings, explore new methodologies, and connect with a community dedicated to innovation in optics. Although there is currently no open access option, the journal's expansive readership and its stability in publication over the decades make it an important platform for both established and emerging researchers in the field.

Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.

MOLECULAR CANCER THERAPEUTICS, published by the American Association for Cancer Research, is a premier journal dedicated to advancing the field of cancer research and therapy since 2001. With a notable impact factor reflecting its high-quality content, this journal stands out in the Q1 category for both Cancer Research and Oncology as of 2023. Researchers, clinicians, and students interested in innovative treatment strategies and molecular mechanisms can find valuable insights within its pages, bolstered by a rigorous peer-review process and a global perspective on cancer therapeutic developments. Although the journal operates under a subscription model, it provides comprehensive access to cutting-edge studies and reviews that drive forward the understanding of cancer biology and treatment modalities. The journal's impressive Scopus rankings further validate its influence within both oncology and the broader cancer research community, making it an indispensable resource for anyone committed to combating cancer through science.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.

LASERS IN SURGERY AND MEDICINE, published by Wiley, is a premier peer-reviewed journal dedicated to advancing the field of laser technology in surgical and medical applications. With an impactful contribution to research since its inception in 1980, this journal has maintained a strong presence in high-impact categories, achieving Q1 status in both Dermatology and Surgery as of 2023. The journal is highly regarded, ranking #69 out of 551 in Medicine—Surgery and #21 out of 142 in Medicine—Dermatology within Scopus, indicating its significant influence in shaping contemporary surgical practices. Although it does not currently offer open access, subscribers and institutions can access a wealth of knowledge through its rigorous publication standards and high-quality research articles. Perfect for researchers, professionals, and students, LASERS IN SURGERY AND MEDICINE is an essential resource for those looking to stay at the forefront of innovations in laser applications across various medical fields.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, published by WORLD SCIENTIFIC PUBL CO PTE LTD, is an influential peer-reviewed journal dedicated to advancing the field of porphyrins and phthalocyanines, key compounds in both chemistry and materials science. With an ISSN of 1088-4246 and an E-ISSN of 1099-1409, this journal has been a vital resource since its inception in 1997 and is expected to continue until 2024. The journal holds a respectable position in the academic landscape, categorized in the Q3 quartile for miscellaneous Chemistry journals and ranked #252 out of 408 in the general chemistry category according to Scopus, reflecting a growing impact in the field despite its current percentile standing at 38th. JOURNAL OF PORPHYRINS AND PHTHALOCYANINES seeks to publish original research articles, reviews, and critical studies that explore the synthesis, characterization, and applications of these versatile compounds, which play essential roles in numerous scientific disciplines, from catalysis to materials development. This journal is an indispensable platform for researchers and professionals seeking to disseminate their findings, engage with contemporary discussions, and stay informed about cutting-edge advancements in porphyrin and phthalocyanine research.